Stories about Real-time polymerase chain reaction

Subscribe to topic

Subscribe to Real-time polymerase chain reaction

18.07.2019 – 12:00
Sysmex Inostics GmbH
Liquid Biopsy performance comparison of Sysmex Inostics OncoBEAM RAS CRC and BioCartis Idylla ctKRAS testing published in Scientific Reports (Nature Journal)
Hamburg, Germany (ots) - Sysmex Inostics, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, today announces publication of a study comparing the performance of plasma RAS mutation detection by two commercial liquid biopsy testing platforms, the OncoBEAM(TM) ...
more
11.04.2019 – 09:00
Debiopharm International SA
GenePOC obtains CE marked for its GenePOC(TM) Carba test
Québec, Canada (ots) - GenePOC Inc., member of the Debiopharm Group, announces its third test to be CE marked, the GenePOC Carba assay, to be used with the revogene(TM) device. About carbapenem-producing organisms (CPO) CPO are considered a serious global public health threat and are associated with significant morbidity, mortality and hospital costs¹. In 2015, 13 of the 38 countries of the European Union and European ...
more
21.03.2019 – 14:00
Debiopharm International SA
GenePOC obtains FDA clearance for its GenePOC(TM) Strep A test in the US
Québec, Canada (ots) - GenePOC Inc., member of the Debiopharm Group, announces its third test to be cleared by the FDA, the GenePOC Strep A assay, to be used with the revogene(TM) device. About Group A Streptococcus (GAS) infection GAS is the most common bacterial etiology of pharyngitis accounting for 15 to 30% cases in children and 5 to 20% in adults[1]. In the ...
more
23.10.2018 – 14:00
Debiopharm International SA
GenePOC® launches its GenePOC® CDiff test in Canada
Québec, Canada (ots) - GenePOC announces the Health Canada approval and launch of its molecular diagnostic test for the detection of Clostridium difficile in Canada GenePOC Inc., member of the Debiopharm Group, is proud to announce the approval by Health Canada and the launch of its GenePOC CDiff assay to be used with the revogene(TM) instrument. About the Clostridium difficile infection (CDI) In Canada, CDI is the main ...
more
18.10.2018 – 12:00
Sysmex Inostics GmbH
Sysmex Inostics' OncoBEAM(TM) platform demonstrates superior detection of clinically-relevant mutations for therapy selection and molecular monitoring for lung and colon cancers
Hamburg, Germany (ots) - Data presented at the European Society of Medical Oncology (ESMO) 2018 meeting in Munich, Germany by three clinical oncology research groups demonstrate the importance of a highly sensitive test for detection of clinically-relevant mutations present in circulating tumor DNA (ctDNA) derived ...
more

1